Grants Search Results

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. One of the two projects funded by this grant is an extension of pervious grant and aims to accurately measure treatment response by counting residual leukemia cells in patients following treatment. The second project is an European clinical trial studying the effectiveness of using antibody treatment together with chemotherapy and surgery for patients with newly diagnosed neuroblastoma.

This grant provides resources to establish a soft tissue sarcoma subspecialty team to improve patient outcomes and ensure the best transition for adults from pediatric survival clinic to adult care.

This NetApp St. Baldrick's Infrastructure grant provides necessary resources to establish a database to help researchers understand potential barriers to enrollment in clinical trials, and develop interventions to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant is named for the NetApp team, whose employees around the world have raised more than $4 million for lifesaving research through the St. Baldrick's Foundation.

This grant provides resources to help build a central database of findings to be available to the pediatric cancer research community to enhance the progression of research. By linking together thousands of scientists and doctors, SAGE Bionetworks will provide tools and key information through a solution called crowd-sourcing.

This grant helps provide necessary resources for the Childhood Cancer Survivorship Program at this institution, enhancing research while providing childhood cancer survivors the support, treatment and education they need to prevent and address late effects.

This grant funds the sustainability of a comprehensive long-term follow-up program and expansion plans to create a transition program with the goal to monitor the medical and psychosocial issues that young cancer patients face as they enter into adulthood.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant develops, implements, and evaluates a novel curriculum in humanism and professionalism for pediatric oncology fellows. Funds will also be used to determine the optimal size of the pediatric hematology-oncology fellow workforce in order to meet the clinical demands of the field.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant helps provide necessary resources to build an early phase clinical trial program, and increase the number of such trial enrollments.

This grant funds a Research Assistant to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Funding from the St. Baldrick's Foundation has taken two very small programs at UIC and Rush Medical Centers, merged them and brought Stroger Medical Center into the fold to forge a single entity for purposes of participation in Children's Oncology Group clinical trials. This support of necessary personnel has significantly increased clinical trial participation for patients who otherwise might not have access to them.

This grant funds a Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Brain tumors are the most common solid cancer in children, and are often cured with radiation therapy. While radiation attacks the tumor, it can also leave the child with significant learning problems that affect their quality of life over the many years following cancer. Dr. Castellino focuses on understanding how heart function and brain vessel function may have been affected during treatment of the brain tumor. The goal of this research is to create strategies to prevent or lessen the injury to the brain during treatment, not only to cure the cancer in children, but also to preserve normal function for productive and healthy lives as cancer survivors.

Leukemia is the most common childhood cancer. Some types of leukemia cells have abnormal genetic material. One of these abnormalities is known to affect the CALM protein, which is essential for the cell to obtain iron from the body that is necessary for cell growth. Dr. Heath believes that leukemias with the abnormal CALM-AF10 protein will not have enough iron and by reducing the amount of iron available to them, the leukemia cells may be affected. This research project attempts to prove that these two mutations can cooperate to form leukemia. Dr. Heath also attempts to show that mutations of WT1 cause cells to function abnormally, which contribute to the development of leukemia. Preliminary work shows that cells with WT1 mutations grow faster and more aggressively. The first model to study the cooperation of FLT3/ITD and WT1 mutations has been created. Ultimately, if WT1 mutations are shown to contribute to the formation of leukemia, the development of a drug that interferes with WT1 could improve cure rates in patients with AML.